INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourag...
29 Octubre 2015 - 3:25PM
Business Wire
The securities litigation law firm of Brower Piven, A
Professional Corporation, has commenced an investigation into
possible breaches of fiduciary duty and other violations of state
law by the Board of Directors of TriVascular Technologies, Inc.
(Nasdaq: TRIV) (“TriVascular” or the “Company”) relating to the
proposed buyout of the Company by Endologix, Inc.
Under the terms of the transaction, TriVascular shareholders are
anticipated to receive a combination of cash and stock to be
determined at the closing of the merger, currently valued at
approximately $9.10 per share. The firm’s investigation seeks to
determine, among other things, whether the Company’s Board of
Directors failed to satisfy their duties to shareholders, including
whether the Board adequately pursued alternatives to the
acquisition and whether the Board obtained the best price possible
for the Company’s shares of common stock (i.e., according to Yahoo!
Finance, at least one Wall Street analyst has issued a price target
for TriVascular stock at $13.00 per share).
If you currently own common stock of TriVascular and believe
that the proposed buyout price is too low, or you would like to
learn more about the investigation being conducted by Brower Piven,
please visit our website at
http://www.browerpiven.com/currentinvestigations.html. You may also
request more information by contacting Brower Piven either by email
at hoffman@browerpiven.com or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in
litigating securities and other class action cases and have been
advocating for the rights of shareholders since the 1980s.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151029006812/en/
Brower Piven, A Professional CorporationCharles J. Piven,
410-415-66161925 Old Valley RoadStevenson, Maryland
21153hoffman@browerpiven.com
TRIVASCULAR TECHNOLOGIES, INC. (NASDAQ:TRIV)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
TRIVASCULAR TECHNOLOGIES, INC. (NASDAQ:TRIV)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
